ANIP
ANI Pharmaceuticals IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$1.88B
P/E Ratio
21.16
EPS
$3.91
Beta
0.46
52W High
$99.50
52W Low
$57.33
50-Day MA
$78.01
200-Day MA
$83.77
Dividend Yield
—
Profit Margin
9.98%
Forward P/E
10.02
PEG Ratio
1.06
About ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets brand-name and generic prescription pharmaceuticals in the United States and Canada. The company is headquartered in Baudette, Minnesota.
Fundamentals
| Revenue (TTM) | $923.71M |
| Gross Profit (TTM) | $561.85M |
| EBITDA | $197.38M |
| Operating Margin | 16.30% |
| Return on Equity | 18.30% |
| Return on Assets | 4.97% |
| Revenue/Share (TTM) | $45.33 |
| Book Value | $26.34 |
| Price-to-Book | 3.35 |
| Price-to-Sales (TTM) | 2.04 |
| EV/Revenue | 2.349 |
| EV/EBITDA | 9.69 |
| Quarterly Earnings Growth (YoY) | 86.10% |
| Quarterly Revenue Growth (YoY) | 20.50% |
| Shares Outstanding | $22.73M |
| Float | $19.46M |
| % Insiders | 6.89% |
| % Institutions | 110.30% |
Historical Volatility
HV 10-Day
31.47%
HV 20-Day
28.88%
HV 30-Day
29.36%
HV 60-Day
32.31%
HV Rank
41.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($109.88 target)
3
Strong Buy4
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026